Value proposition

Pioneering Ion Channels

Sophion was founded in the year 2000 by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”.

Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persist.

With our complete technical, biological and application support we help our partners to achieve their targets, and through the continued development of our QPatch and Qube platforms, we ensure that we offer uncompromised data quality in a user-friendly environment from assay setup to data analysis.

Automated Patch Clamping, Drug Discovery, Ion channels, High throughput screening, HTS, QCells, QPatch, Qube, Automated Patch Clamp, QPatchII, Sophion, QPatchCompact, Qube384, Electrophysiology, Large Molecules, and ICMS2022